Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells?

Bone Marrow Transplantation

Volumn 23, Issue 8, 1999, Pages 847-848

  Yano, M ^a,b   Watanabe, A ^a,b   Kawano, Y ^c   Watanabe, T ^c   Takaue, Y ^c,d  

^a AKITA UNIVERSITY   (Japan)

^b Nakadori Hospital   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Bone marrow cavity; CD34+ cells; Stem cell transplantation

Indexed keywords

CD34 ANTIGEN;

ARTICLE; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISPOSABLE EQUIPMENT; FEMALE; HEMATOPOIESIS; HLA MATCHING; HUMAN; KIDNEY FAILURE; NEEDLE; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032892623     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701662     Document Type: Article

References (5)

1. Hagglund H, Ringden O, Agren B, Wennberg L. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant 1998; 21: 331-335.
2. + selection of granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood progenitor cells. Blood 1996; 88: 1517-1518.
3. Rosetti VA, Thompson BM, Miller J, Mateer JR. Intraosseous infusion: an alternative route of pediatric intravascular access. Ann Emerg Med 1985; 14: 885-888.
4. Webb IJ, Coral FS, Andersen JW, Elias AD. Sources and sequelae of bacterial contamination of hematopoietic stem cell component: implications for the safety of hematotherapy and graft engineering. Transfusion 1996; 36: 782-788.
5. + selected cells in patients with advanced malignancies: severe immunodeficiency and related complications. Br J Haematol 1997; 98: 760-766.